Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Alcon IPO: Swiss eye care company reports sales of $707 mil., up 8%, in its first quarter as an independent entity following its March 20 initial public offering of 76.7 mil. shares of common stock at $33 each - which raised net proceeds of roughly $2.4 bil. (1"The Gray Sheet" March 4, 2002, p. 22). Surgical unit revenue of $338 mil. was ahead 4%, anchored by AcrySof intraocular lens sales of $102 mil...

You may also be interested in...



Sunrise Technologies

Chapter 7 bankruptcy filing is made in Oakland, California district court to assist in liquidation of the Menlo Park firm's assets, which primarily relate to the Hyperion laser thermal keratoplasty system. The holmium YAG laser was approved in 2000 for temporary hyperopia reduction of up to 2 diopters by shrinking collagen in the eye. A March reorganization plan failed to gain sufficient support from secured creditors (1"The Gray Sheet" May 13, 2002, p. 12)...

Sunrise Technologies

Chapter 7 bankruptcy filing is made in Oakland, California district court to assist in liquidation of the Menlo Park firm's assets, which primarily relate to the Hyperion laser thermal keratoplasty system. The holmium YAG laser was approved in 2000 for temporary hyperopia reduction of up to 2 diopters by shrinking collagen in the eye. A March reorganization plan failed to gain sufficient support from secured creditors (1"The Gray Sheet" May 13, 2002, p. 12)...

Alcon To Keep R&D Focus After Spin-Off From Parent Nestle By April Via IPO

Alcon plans to spend $1.4 bil. on research and development over the next four years as an independent company, following its spin-off from Nestle

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel